© Reuters. FILE PHOTO: Signage is seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S. August 29, 2020. REUTERS/Andrew Kelly/File Photo
(Reuters) – Mead Johnson Nutrition (MJN), part of the Reckitt Benckiser Group, is voluntarily recalling certain lots of Nutramigen powder from the U.S. market due to possible contamination with Cronobacter sakazakii bacteria in products sampled outside the United States, said the Food and Drug Administration. Sunday.
Nutramigen Powder, a specialized infant formula for the dietary management of cow’s milk allergy (CMA) in 12.6- and 19.8-ounce cans, has been extensively tested by MJN and found to be negative for the bacteria, the FDA said.
Nutramigen containers were manufactured in June 2023 and distributed primarily in June, July and August, the FDA said.
“Based on the limited availability of remaining stock of this special infant formula, it is estimated that many, if not all, of the recalled products in the United States have been consumed,” the FDA said, adding that no cases of illness have been reported. or adverse events to date.
All recalled products have a “use by date” of “January 1, 2025,” Reckitt said, asking customers to discard the products if they belong to the recalled lots.
“No other lots of Nutramigen distributed in the United States or any other Reckitt products are affected,” Reckitt said.
Cronobacter bacteria can cause serious and even fatal infections or meningitis. The infection can also cause intestinal damage and spread through the blood to other parts of the body.